Name | Type | Posted | Actions |
|---|---|---|---|
Attachment 0001_Government Questions To Industry_Electro-Theraputic Modalities-TENS_Fillable.docx | DOCX | Jun 9, 2026 |
FY26 Recompete of the Transcutaneous Electrical Nerve Stimulation (TENS) Requirement with the inclusion of the new Electro-Therapeutic Modalities for Pain Management (ETMPM) Requirement.
The Veterans Health Administration (VHA) is conducting market research for the Fiscal Year 2026 (FY26) procurement of Electro-Therapeutic Modalities for Pain Management (ETMPM) and Transcutaneous Electrical Nerve Stimulation (TENS) units. This requirement consolidates the legacy contract 36C79122D0005 and expands the scope to include Interferential Current (IFC) units, Short Wave Diathermy units, and Neuromodulation devices. The program supports non-pharmacological pain management across 168 VA Medical Centers and over 1,000 outpatient clinics. The VA plans to use Firm-Fixed-Price (FFP) Indefinite-Delivery/Indefinite-Quantity (IDIQ) contracts with centralized distribution through the Denver Logistics Center (DLC) in Golden, Colorado, using the Remote Order Entry System (ROES). The agency is transitioning to a direct purchase model, excluding rental or usage-based agreements. Responses to this RFI are due by June 26, 2026, and must include HCPCS codes and delivery lead times. The current legacy contract expires on January 19, 2027. The VA is moving to a volume-based acquisition strategy using FFP IDIQ contracts. This model emphasizes supply chain efficiency through centralized distribution at the Denver Logistics Center and electronic ordering via ROES. The agency intends to use a direct purchase model rather than rentals or subscriptions to ensure nationwide availability and price stability. Devices must be FDA-compliant and meet OEM warranty standards. Gray-market goods are not permitted. Suppliers must provide commercial delivery lead times and specific timelines for the first delivery to the DLS.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.
Contact and place of performance
John Overstake
Golden, CO 80401
USA
Request For Information (RFI) From: Department of Veterans Affairs (VA) Veterans Health Administration (VHA) National Prosthetic & Sensory Aids Service (PSAS) National Acquisition Center (NAC) Commodities & Services Acquisition Service (CSAS) Subject: FY26 Recompete of the Transcutaneous Electrical Nerve Stimulation (TENS) Requirement with the inclusion of the new Electro-Therapeutic Modalities for Pain Manag...
View moreContract Line Item Numbers (CLINs):
The anticipated FY26 solicitation will include the following CLINs:
Question For Industry:
The Government is respectfully requesting all industry participants who are interested in this requirement and likely to be prospective Offerors to the resultant solicitation for this requirement to respond to the following questions:
Additional Information:
Disclaimer:
This Presolicitation Notice is issued solely for market research purposes and informational planning and strategy. It does not constitute a solicitation or a promise to issue a solicitation. No contract award will result from this notice.
Government Designated Point of Contact:
John Overstake
Contract Specialist
Department of Veterans Affairs
Email: [email protected]
Phone: (720) 497-2304
RFI Respondent Instructions:
All interested Respondents to this RFI are respectfully requested to complete the Attachment 0001 – Government’s Questions to Industry document and follow these document submission steps:
Closing Remarks:
The Department of Veterans Affairs (VA) extends its deepest appreciation to all industry partners for their participation and heightened interest in the FY26 Recompete of the Transcutaneous Electrical Nerve Stimulation (TENS) Program and the expanded Electro‑Therapeutic Modalities for Pain Management (ETMPM) Requirement.
The VA further acknowledges the professionalism and engagement demonstrated during the VA’s Industry Days held at the Denver Logistics Services (DLS) facility in Golden, Colorado from February 24–26, 2026. Your presence and contributions during these sessions reflect a meaningful and shared commitment to improving non‑opioid pain‑management solutions for this great nation’s Veterans.
The VA recognizes and values the time, energy, and thoughtful collaboration provided by prospective suppliers during this critical early phase of the acquisition process. Your awareness and industry expertise play an essential role in shaping a competitive, transparent, and well‑informed procurement environment that ensures America’s Veterans receive safe, reliable, clinically effective therapeutic devices that support their long‑term health and well‑being. The insights shared by industry partners are instrumental to the VA’s planning efforts, helping us refine requirements, enhance acquisition clarity, and uphold the highest standards of clinical readiness and supply chain resilience.
This procurement effort supports a solemn national promise reaffirmed through every VA program: “To care for those who have borne the battle in service to the United States.” The modernization of the TENS requirement and its strategic integration with advanced ETMPM technologies reflect the VA’s dedication to expanding evidence‑based, non-pharmacological modalities that directly enhance the quality of life for millions of Veterans living with acute and chronic pain conditions. Meeting this mission cannot occur without the dedication, capability, and integrity of committed private‑sector partners.
The Government sincerely appreciates industry’s continued engagement and the comprehensive market feedback received during this RFI stage. As this requirement progresses toward formal solicitation, we look forward to the ongoing partnership of qualified suppliers who share our commitment to delivering exceptional clinical tools, strengthening national logistics support, and honoring the sacrifice of those who served. Your continued collaboration enhances the VA’s ability to execute a timely, high‑quality, and mission‑aligned procurement process that will enable consistent access to critical pain‑management technologies across all VA medical facilities.
All future updates, timelines, and acquisition instructions will be communicated exclusively through the Governmentwide Point of Entry (GPE) at www.sam.gov. The Department of Veterans Affairs extends its sincere gratitude for your professionalism, attentiveness, and dedication to our Veterans. We value your partnership and look forward to your continued participation as this important requirement advances toward formal competition.